Niche Markets and Rare Diseases

Syndicated Market Research for Assessing Niche Pharmaceutical Markets

• Download brochure
  

As pharmaceutical companies seek new areas for growth, Decision Resources is offering the first series of syndicated research covering niche pharmaceutical markets. This service provides the insights needed to understand the competitive landscape and market opportunities for a given disease, helping companies save time and resources compared with expensive consulting engagements.

Each report assesses the commercial opportunity of a select drug market across the United States, France, Germany, Italy, Spain and the United Kingdom and includes:

• World-class epidemiology data with fully transparent methodologies and sources
  • Patient population estimates and projections are accompanied by full discussions of the reasons for including select studies as sources for the underlying data and why other studies were omitted
  • For cancers, Decision Resources’ team of epidemiologists calculate treatable pools of patients. This can be used for greater accuracy in forecasting and sizing a cancer market by taking into account both relevant patient populations AND patient populations by stages
• Robust thought leader insight
  • Interviews with key opinion leaders in the United States and Europe are conducted by Decision Resources’ therapeutic area experts to uncover unmet needs and opportunities in the market
• High quality assessment of emerging therapies
  • Evaluation of the likely positioning, receptivity, uptake and commercial potential of emerging products

Key benefits:  

• Assessment of the market dynamics and opportunity for a key drug market in the G7
• Best-in-class epidemiology data with fully transparent methodologies and sources
• Peak year sales forecast of emerging therapies
• Disease-area expert analysts who leverage a broad range of primary research to inform analysis
• PowerPoint deliverable for easy incorporation into users’ presentations and reports